BG106209A - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- BG106209A BG106209A BG06209A BG10620901A BG106209A BG 106209 A BG106209 A BG 106209A BG 06209 A BG06209 A BG 06209A BG 10620901 A BG10620901 A BG 10620901A BG 106209 A BG106209 A BG 106209A
- Authority
- BG
- Bulgaria
- Prior art keywords
- therapeutic agents
- human
- compound
- treatment
- effective amount
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- 229940086609 Lipase inhibitor Drugs 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 abstract 1
- 229960001243 orlistat Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Child & Adolescent Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A method for the treatment of obesity and associated co-morbid conditions in a human in need of such treatment which comprises administration to the human of a therapeutically effective amount of a compound of formula including enantiomers and pharmaceutically acceptable salts thereof, in which R1 and R2 are independently H or methyl, and a therapeutically effective amount of lipase inhibitor with the exception of orlistat, wherein the compound and the lipase inhibitor are administered simultaneously, separately or sequentially. 8 claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9914742.3A GB9914742D0 (en) | 1999-06-24 | 1999-06-24 | Therapeutic agents |
| PCT/EP2000/005544 WO2001000187A2 (en) | 1999-06-24 | 2000-06-16 | Pharmaceutical composition containing sibutramine and a lipase inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG106209A true BG106209A (en) | 2002-09-30 |
Family
ID=10855953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG06209A BG106209A (en) | 1999-06-24 | 2001-12-11 | Therapeutic agents |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1189638A2 (en) |
| JP (1) | JP2003503344A (en) |
| KR (1) | KR20020012293A (en) |
| CN (1) | CN1365287A (en) |
| AU (1) | AU5815100A (en) |
| BG (1) | BG106209A (en) |
| BR (1) | BR0011884A (en) |
| CA (1) | CA2376213A1 (en) |
| CZ (1) | CZ20014614A3 (en) |
| GB (1) | GB9914742D0 (en) |
| HK (1) | HK1050476A1 (en) |
| HU (1) | HUP0201880A3 (en) |
| IL (1) | IL147078A0 (en) |
| MX (1) | MXPA01013023A (en) |
| NO (1) | NO20016301L (en) |
| PL (1) | PL352387A1 (en) |
| SK (1) | SK18822001A3 (en) |
| TR (1) | TR200103704T2 (en) |
| WO (1) | WO2001000187A2 (en) |
| ZA (1) | ZA200110046B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6399826B1 (en) * | 1999-08-11 | 2002-06-04 | Sepracor Inc. | Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
| US7089666B2 (en) * | 2003-06-06 | 2006-08-15 | The Regents Of The University Of California | Microfabricated vertical comb actuator using plastic deformation |
| MX2009002781A (en) | 2006-09-15 | 2009-03-30 | Reviva Pharmaceuticals Inc | Synthesis, methods of using, and compositions of cycloalkylmethylamines. |
| US8604244B2 (en) | 2010-07-02 | 2013-12-10 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives |
| CN101890017A (en) * | 2009-05-22 | 2010-11-24 | 北京奥萨医药研究中心有限公司 | Medicament composition containing sibutramine and stanin fat-reducing medicament and application thereof |
| ES2726807T3 (en) | 2011-12-30 | 2019-10-09 | Reviva Pharmaceuticals Inc | Compositions, synthesis and methods of use of 1- [1-phenyl-cyclobutyl] isobutylamine derivatives |
-
1999
- 1999-06-24 GB GBGB9914742.3A patent/GB9914742D0/en not_active Ceased
-
2000
- 2000-06-16 JP JP2001505897A patent/JP2003503344A/en active Pending
- 2000-06-16 BR BR0011884-2A patent/BR0011884A/en not_active IP Right Cessation
- 2000-06-16 CN CN00810544A patent/CN1365287A/en active Pending
- 2000-06-16 EP EP00943819A patent/EP1189638A2/en not_active Withdrawn
- 2000-06-16 CA CA002376213A patent/CA2376213A1/en not_active Abandoned
- 2000-06-16 SK SK1882-2001A patent/SK18822001A3/en unknown
- 2000-06-16 HK HK03101311.7A patent/HK1050476A1/en unknown
- 2000-06-16 WO PCT/EP2000/005544 patent/WO2001000187A2/en not_active Ceased
- 2000-06-16 TR TR2001/03704T patent/TR200103704T2/en unknown
- 2000-06-16 PL PL00352387A patent/PL352387A1/en unknown
- 2000-06-16 MX MXPA01013023A patent/MXPA01013023A/en unknown
- 2000-06-16 HU HU0201880A patent/HUP0201880A3/en unknown
- 2000-06-16 CZ CZ20014614A patent/CZ20014614A3/en unknown
- 2000-06-16 AU AU58151/00A patent/AU5815100A/en not_active Abandoned
- 2000-06-16 IL IL14707800A patent/IL147078A0/en unknown
- 2000-06-16 KR KR1020017016577A patent/KR20020012293A/en not_active Ceased
-
2001
- 2001-12-06 ZA ZA200110046A patent/ZA200110046B/en unknown
- 2001-12-11 BG BG06209A patent/BG106209A/en unknown
- 2001-12-21 NO NO20016301A patent/NO20016301L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001000187A3 (en) | 2001-11-15 |
| ZA200110046B (en) | 2003-03-06 |
| HUP0201880A3 (en) | 2003-03-28 |
| CZ20014614A3 (en) | 2004-02-18 |
| CN1365287A (en) | 2002-08-21 |
| IL147078A0 (en) | 2002-08-14 |
| BR0011884A (en) | 2003-08-12 |
| NO20016301D0 (en) | 2001-12-21 |
| NO20016301L (en) | 2001-12-21 |
| GB9914742D0 (en) | 1999-08-25 |
| EP1189638A2 (en) | 2002-03-27 |
| AU5815100A (en) | 2001-01-31 |
| SK18822001A3 (en) | 2003-04-01 |
| CA2376213A1 (en) | 2001-01-04 |
| HK1050476A1 (en) | 2003-06-27 |
| MXPA01013023A (en) | 2003-08-01 |
| HUP0201880A2 (en) | 2002-12-28 |
| KR20020012293A (en) | 2002-02-15 |
| PL352387A1 (en) | 2003-08-25 |
| WO2001000187A2 (en) | 2001-01-04 |
| JP2003503344A (en) | 2003-01-28 |
| TR200103704T2 (en) | 2002-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG104476A (en) | Therapeutical form for tolterodin with controlled release | |
| EG25822A (en) | Quinolinyl-pyrrolopyrazoles | |
| GB2254784B (en) | Film-coated solid dosage form of anti-migraine drug | |
| BG106586A (en) | Pyrazolopyramidines as therapeutic agents | |
| AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
| NZ514574A (en) | Novel method of treatment | |
| DE60316779D1 (en) | THIADIAZOLYLPIPERAZINE DERIVATIVES SUITABLE FOR THE TREATMENT OF BZW. PREVENTION OF PAIN | |
| GEP20043269B (en) | Purine Derivatives, Method for Their Production and Composition Containing the Same | |
| PL342099A1 (en) | Therapeutic agents | |
| LU91254I2 (en) | Daptomycin and its pharmaceutically acceptable derivatives (cubicinr) | |
| MY119375A (en) | Treatment of tinnitus using neuroprotective agents | |
| CY1107465T1 (en) | MELAGATRANI FOR THERAPEUTIC INFECTION | |
| BG106180A (en) | Pharmaceutical composition containing sibutramine and orlistat | |
| BG106209A (en) | Therapeutic agents | |
| BG105997A (en) | Method of controlling weight gain associated with therapeutic drugs | |
| IL146962A0 (en) | Aminotetralin derivatives for the therapy of cardiovascular diseases | |
| EP1347754A4 (en) | Compositions for adhesion prevention | |
| MX9800916A (en) | Use of basic amino acids and derivatives for lowering ceramide levels. |